India to Indonesia: Antitoxin Export Trade Route
India has recorded 8 verified shipments of Antitoxin exported to Indonesia, representing a combined trade value of $715.2K USD. This corridor is served by 3 active Indian exporters, with an average shipment value of $89.4K USD. The leading Indian exporter is VINS BIOPRODUCTS LIMITED, which accounts for 53% of total export value with 4 shipments worth $375.6K USD. On the buying side, CUST ID:AWY BACL001 is the largest importer in Indonesia with $231.4K USD in purchases. The top 3 suppliers — VINS BIOPRODUCTS LIMITED, VINS BIOPRODUCTS LIMITED , VINS BIOPRODUCTS LTD — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Indonesia Antitoxin corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $715.2K USD. The route is dominated by VINS BIOPRODUCTS LIMITED, which alone accounts for roughly 53% of all export value, reflecting the consolidated nature of India's antitoxin manufacturing sector.
Across 3 active suppliers, the average shipment value stands at $89.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with antitoxin's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 58.9%, placing it at rank #3 among India's top antitoxin export destinations globally.
On the import side, key buyers of Indian antitoxin in Indonesia include CUST ID:AWY BACL001, IFBTP , IFBTB and 3 others. CUST ID:AWY BACL001 is the single largest importer with 2 shipments valued at $231.4K USD.
